Table1. Clinical data of patients.
No | Diagnosis | Age | Sex | BCR-ABL quantification | TKI naive | Blood/BM |
---|---|---|---|---|---|---|
1 | CP-CML | 40 | M | 60.19% | Y | BM |
2 | CP-CML | 18 | F | 69.67% | Y | BM |
3 | CP-CML | 8 | M | 72.3% | Y | Blood |
4 | CP-CML | 58 | F | 50.3% | Y | BM |
5 | CP-CML | 11 | M | 74.45% | Y | BM |
6 | CP-CML | 55 | M | 65.65% | N | Blood |
7 | CP-CML | 59 | F | 67.45% | Y | BM |
8 | BC-CML | 63 | F | 76.32% | N | BM |
9 | CP-CML | 1 | F | 49.4% | Y | BM |
10 | CP-CML | 50 | M | 62.49% | N | BM |
11 | BC-CML | 65 | M | 75.2% | N | BM |
12 | BC-CML | 17 | M | 63.2% | N | BM |
13 | BC-CML | 58 | F | 51.3% | N | BM |
Abbreviations: BC-CML, blast crisis of CML; BM, bone marrow; CP-CML, chronic phase of CML; F, female; M, male; N, no; Y, yes.